Cancer medicines
Ribociclib
Ribociclib
A CDK4/6 inhibitor paired with endocrine therapy in selected early or advanced breast cancers.
Sources checked · Introductory guide
On this page
How it works
It inhibits CDK4 and CDK6 to slow cancer cell division.[3]
Where it is used
Used with endocrine therapy in HR-positive, HER2-negative breast cancer according to stage, recurrence risk and prior therapy.[1]
Key safety points
Confirm ECG, electrolytes, blood counts and liver tests. Report fainting, palpitations, fever or jaundice immediately.[2]
Questions for your care team
- How are heart rhythm, interactions, tests and treatment breaks managed?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- NCI · Ribociclib Succinate (opens in a new tab)
- MedlinePlus · Ribociclib Succinate (opens in a new tab)
- NCI Drug Dictionary · Ribociclib Succinate (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.